Tirzepatide
Basic Information
| Item | Value |
|---|---|
| DrugBank ID | DB15171 |
| Evidence Level | L5 (Computational Prediction) |
| Number of Predicted Indications | 23 |
Predicted Indications (TxGNN)
The following are potential new indications predicted by the TxGNN model. Higher scores indicate higher predicted relevance.
| # | Indication | Source |
|---|---|---|
| 1 | gout | KG + DL |
| 2 | osteoarthritis | KG + DL |
| 3 | pseudoachondroplasia | KG + DL |
| 4 | osteoarthritis susceptibility | KG + DL |
| 5 | benign prostatic hyperplasia (disease) | KG + DL |
| 6 | rheumatoid arthritis | KG + DL |
| 7 | acromesomelic dysplasia, Hunter-Thompson type | KG + DL |
| 8 | brachyolmia | KG + DL |
| 9 | brachyolmia-amelogenesis imperfecta syndrome | KG + DL |
| 10 | myosclerosis | KG + DL |
| 11 | idiopathic granulomatous myositis | KG + DL |
| 12 | myositis fibrosa | KG + DL |
| 13 | headache disorder | KG + DL |
| 14 | Prinzmetal angina | KG + DL |
| 15 | tendinitis | KG + DL |
| 16 | arthropathy | KG + DL |
| 17 | trigeminal autonomic cephalalgia | KG + DL |
| 18 | female breast carcinoma | KG + DL |
| 19 | colobomatous microphthalmia-rhizomelic dysplasia syndrome | KG + DL |
| 20 | brachydactyly-syndactyly syndrome | KG + DL |
| 21 | fibromyalgia | KG + DL |
| 22 | inclusion body myositis | KG + DL |
| 23 | type 1 diabetes mellitus | KG + DL |
Disclaimer
These predictions are for research purposes only and do not constitute medical advice. Clinical validation is required before any clinical application.